PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 8, 2026Journal of Clinical Investigation0 citationsOpen Access

TP53/TAU axis regulates microtubule bundling to control alveolar stem cell mediated regeneration

SKSatoshi KonishiKEKhaliun EnkhbayarSLShuyu Liu

Key Points

  • This research aims to understand how TP53 and TAU regulate microtubule bundling during alveolar stem cell differentiation and regeneration.
  • Utilized AT2 cell cultures for differentiation studies
  • Implemented in vivo genetic loss of function models in mice and humans
  • Conducted GWAS analysis for risk variants in lung diseases
  • Confirmed that AT2s transform into thin AT1s via distinct thick microtubule bundling
  • Found that manipulation of TAU levels disrupts microtubule organization and AT1 morphology
  • Demonstrated increased tissue fibrosis with TAU dysregulation post-injury
  • Identified TP53 as a regulator of TAU expression, with loss of TP53 mimicking TAU deficiency effects

Abstract

Cells exhibit diverse sizes and shapes, tailored for functional needs of tissues. Lung alveoli are lined by large, extremely thin epithelial alveolar type-1 cells (AT1s). Their characteristic morphology is essential for lung function and must be restored after injury. The mechanisms underlying small, cuboidal alveolar type-2 cells (AT2s) differentiation into thin AT1s remain elusive. Here, we demonstrated that AT2s undergo a stepwise morphological transformation characterized by the development of a unique thick microtubule (MT) bundle organization, critical for AT1 morphology. Using AT2 cultures and in vivo genetic loss of function models, we found that MT bundling process occurs in a transitional cell state during AT2 differentiation and was regulated by the TP53/TAU signaling axis. Notably, TAU underwent a linear clustering process, forming beads-on-a-string-like pattern that preceded thick MT-bundle formation. Genetic gain or loss of function of TAU in mouse or human models, prevented the formation of thick MT-bundles, highlighting the critical role of precise TAU levels in generating ultra-thin AT1s. This defect was associated with increased tissue fibrosis following bleomycin-induced injury in vivo. GWAS analysis revealed risk variants in MAPT locus in lung diseases. Moreover, TP53 controlled TAU expression and its loss phenocopied TAU deficiency. This work revealed an unexpected role for TAU in organizing MT-bundles during AT2 differentiation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Konishi et al. (2026) studied this question.

synapsesocial.com/papers/698829520fc35cd7a8849832https://doi.org/10.1172/jci194762
Ask AI
Helpful
Bookmark
Share
View Full Paper